Community-derived protocol. No clinical trials have studied this specific combination. For educational reference only.

GH / Muscle Growth Stack

community

Growth · 3 compounds

CJC-1295 (no DAC) + Ipamorelin for synergistic pulsatile GH release. Optional Tesamorelin.

Community-derived protocol. No clinical trials exist for this combination. For research and educational purposes only.

Why This Stack

Synergistic pulsatile GH release. CJC-1295 (no DAC) extends pulse duration while Ipamorelin provides selective GH secretion without elevating cortisol/prolactin. Tesamorelin optional as additional GHRH analog.

Compounds

CJC-1295 (no DAC) / Modified GRF 1-29

GHRH pulse extension

100 mcg SC before bed

Ipamorelin

Selective GH release

100-200 mcg SC before bed (same syringe)

Tesamorelin

Additional GHRH (optional)

2 mg daily SC (if adding)

Protocol

Duration

12-16 weeks

Cycling

12-16 weeks on, 4-8 weeks off

Timing

Inject CJC + Ipamorelin together SC ~30 min before bed

Reconstitution Quick Reference

Compound	Vial	BAC Water	Concentration
CJC-1295 (no DAC) / Modified GRF 1-29	2 mg	2 mL	1.00 mg/mL
Ipamorelin	2 mg	2 mL	1.00 mg/mL
Tesamorelin	2 mg	2 mL	1.00 mg/mL

Stack Calculator

Estimate cost

Citations

[1]Ipamorelin Characterization. Eur J Endocrinol, 139(5). (Reviewed: 2026-04-12)
[2]CJC-1295 GHRH Analog. Growth Hormone & IGF Research, 16(S1). (Reviewed: 2026-04-12)